SEC Form 4 · accession 0001654954-18-014274
PREMIER BIOMEDICAL INC · BIEI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Pauly
Director
Period of report
Dec 20, 2018
Accepted (ET)
Dec 26, 2018 · 1:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001515740
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $0.09 | Dec 20, 2018 | A | 52,500 | A | Dec 20, 2018 | Dec 20, 2025 | Common Stock | 52,500 | 52,500 | D |
| Warrant (right to buy) | $1.25 | holding | — | — | — | Dec 22, 2017 | Dec 22, 2024 | Common Stock | 8,000 | 8,000 | D |